본문 바로가기
KERD
논문KCI 등재

淸肝解鬱湯과 十六味流氣飮의 유방암에 대한 항암, 항염 효능 연구

Research on the Anti-Breast Cancer and Anti-Inflammatory Effects of Chungganhaewool-tang and Shipyeukmiyeugi-eum

조성희|정민재|류효경
대한한방부인과학회 (The Society Of Oriental Obstetrics & Gynecology)|2022.08|대한한방부인과학회지 (The Journal of Oriental Obstetrics ＆ Gynecology)|제35권 제3호|pp. 1-23|DOI 10.15204/jkobgy.2022.35.3.001

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

breast cancerChungganhaewool-tangShipyeukmiyeugi-eum
주제분류한의학

초록

Objectives: The purpose of this study is to evaluate anti-breast cancer and anti-inflammatory effects of Chungganhaewool-tang and Shipyeukmiyeugi-eum. Methods: MDA-MB-231 cells were used to measure cytotoxicity, Reactive oxygen species (ROS) production, protein expression amounts of Bcl-2-associated X protein (Bax), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), Cytochrome C Caspase-3, Caspase-7, Caspase-9, Poly ADP-ribose polymerase (PARP), Nuclear factor erythroid-2-related factor 2 (Nrf2), Heme oxygenase-1 (HO-1) and NAD (P) H Quinone Oxidoreductase 1 (NQO1) to evaluate the anti-breast cancer effects of Chungganhaewool-tang (CHT) and Shipyeukmiyeugi-eum (SYE), and THP-1 cells, differentiated into macrophage and induced inflammation with Lipopolysaccharide (LPS), were used to measure production amounts of ROS, Nitric oxide (NO), and protein expression amounts of Inducible nitric oxide synthase (iNOS), Cyclooxygenase (COX-2), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6) and Tumor necrosis factor-alpha (TNF-α) to evaluate the anti-inflammatory effects of CHT and SYE. Results: CHT and SYE reduced MDA-MB-231 cell counts, increased protein expression of Bax and Cytochrome C, and decreased protein expression of Bcl-2, Bcl-xl. The protein expression amounts of Caspase-3, 7, and 9 decreased, but amounts of the active form, cleaved Caspase-3, 7, and 9, increased. In addition, PARP protein expression decreased, the amount of PARP protein in the cleaved form increased, and the amount of protein expressions of Nrf2 and HO-1 decreased, but NQO1 showed no significant difference. In THP-1 cells CHT and SYE reduced ROS and NO, and reduced protein expressions of iNOS, COX-2, IL-1, and TNF-α, but only SYE groups reduced IL-6. Conclusions: This study suggests that CHT and SYE have potential to be used as treatments for breast cancer.

Abstract

Objectives: The purpose of this study is to evaluate anti-breast cancer and anti-inflammatory effects of Chungganhaewool-tang and Shipyeukmiyeugi-eum. Methods: MDA-MB-231 cells were used to measure cytotoxicity, Reactive oxygen species (ROS) production, protein expression amounts of Bcl-2-associated X protein (Bax), B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xl), Cytochrome C Caspase-3, Caspase-7, Caspase-9, Poly ADP-ribose polymerase (PARP), Nuclear factor erythroid-2-related factor 2 (Nrf2), Heme oxygenase-1 (HO-1) and NAD (P) H Quinone Oxidoreductase 1 (NQO1) to evaluate the anti-breast cancer effects of Chungganhaewool-tang (CHT) and Shipyeukmiyeugi-eum (SYE), and THP-1 cells, differentiated into macrophage and induced inflammation with Lipopolysaccharide (LPS), were used to measure production amounts of ROS, Nitric oxide (NO), and protein expression amounts of Inducible nitric oxide synthase (iNOS), Cyclooxygenase (COX-2), Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6) and Tumor necrosis factor-alpha (TNF-α) to evaluate the anti-inflammatory effects of CHT and SYE. Results: CHT and SYE reduced MDA-MB-231 cell counts, increased protein expression of Bax and Cytochrome C, and decreased protein expression of Bcl-2, Bcl-xl. The protein expression amounts of Caspase-3, 7, and 9 decreased, but amounts of the active form, cleaved Caspase-3, 7, and 9, increased. In addition, PARP protein expression decreased, the amount of PARP protein in the cleaved form increased, and the amount of protein expressions of Nrf2 and HO-1 decreased, but NQO1 showed no significant difference. In THP-1 cells CHT and SYE reduced ROS and NO, and reduced protein expressions of iNOS, COX-2, IL-1, and TNF-α, but only SYE groups reduced IL-6. Conclusions: This study suggests that CHT and SYE have potential to be used as treatments for breast cancer.

참고문헌 (43)

  1. Sung HA, "Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries", CA : CA Cancer J Clin, 71(3), pp.209~249 (2021)
  2. Annual report of cancer statistics in Korea in 2018, "Korea Central Cancer Registry. National Cancer Center", Ministry of Health and Welfare, 22~ (2020)
  3. Park JG, "Oncology", pp.596~597 (2012), Ilchokak
  4. 조현일, "유방질환 및 유럽의 유방암 진료 시스템에 대한 고찰", Obstetrics & Gynecology Science, 53(07), pp.565~578 (2010), 대한산부인과학회
  5. 노오규, "Probabilities of Pulmonary and Cardiac Complications and Radiographic Parameters in Breast Cancer Radiotherapy", Radiation oncology journal, 28(1), pp.23~31 (2010), 대한방사선종양학회
  6. Smoot B, "Breast Cancer Treatments and Complications : Implications for Rehabilitation", Phys Ther J Policy Adm Leadersh, 27(3), pp.16~26 (2009)
  7. Kayl AE, "Side-effects of chemotherapy and quality of life in ovarian and breast cancer patients", Curr Opin Gynecol Obstet, 18(1), pp.24~28 (2006)
  8. Dodd MJ, "Symptom clusters and their effect on the functional status of patients with cancer", Oncol Nurs Forum, 28(3), pp.465~470 (2001)
  9. 이태복, "Can Hinokitiol Kill Cancer Cells? Alternative Therapeutic Anticancer Agent via Autophagy and Apoptosis", 대한임상검사과학회지, 51(2), pp.221~234 (2019), 대한임상검사과학회[DOI]
  10. 오하나, "패독산류의 구강편평세포암종 및 악성중피종에 대한 항암 활성", 생약학회지, 48(3), pp.213~218 (2017), 한국생약학회
  11. 조승식, "세신 비극성 분획의 항암 활성 및 성분 분석", 생약학회지, 51(4), pp.264~269 (2020), 한국생약학회[DOI]
  12. 남기열, "Ginsenoside Rg3의 항암효능 연구의 진보", 생약학회지, 45(1), pp.1~10 (2014), 한국생약학회
  13. Song JY, "Screening of Antineoplastic Immunomodulator from Herbal Medicines", Yakhak Hoeji, 42(2), pp.132~139 (1998)
  14. Han DS, "Development of Anticancer Agents from Korean Medicinal Plants (Part 10). The Growth-inhibitory Effect of Taraxaci Herba Extract Against Human Skin Melamoma Cells", J. Toxicol. Pub. Health, 14(4), pp.489~494 (1998)
  15. The Society of Korean Medicine Obstetrics & Gynecology, "Korean Medicine Obstetrics and Gynecology (Vol 2)", pp.459~ (2021), Euiseongdang
  16. Shin JY(申載鏞), "Bangyakhappyeonhaeseol (方藥合編解說)", pp.178~179 (1993), Shingwang-munhwasa
  17. 서부일, "A clinical study on a patient with postpartum depression and acute mastitis", 대한본초학회지, 18(1), pp.17~148 (2003), 대한본초학회
  18. Yi JE, "Effects of Sipyukmiyuki -eum on DNA Synthesis, cAMP Synthesis and MHC-class II Expression of FRTL-5 Thyroid Cells", Korean J. Orient. Int. Med, 26(2), pp.398~408 (2005)
  19. Jeoung YH, "Studies on Effects of Sipyukmiyuki-eum on the Hyperthyroidism", The Journal of K.O.M.S, 9(2), pp.98~108 (1988)
  20. 정연철, "十六味流氣飮의 免疫活性에 의한 乳房癌 세포 成長抑制效果", 대한한방부인과학회지, 25(3), pp.40~60 (2012), 대한한방부인과학회[DOI]
  21. Allavena P, "Pathways connecting inflammation and cancer", Curr Opin Genet Dev, 18(1), pp.3~10 (2008)
  22. Heo J(許浚), "Donguibogam(東醫寶鑑)", pp.764~766 (2012), Bubin-munhwasa
  23. Lowe SW, "Apoptosis in Cancer", Carcinogenesis, 21(3), pp.485~495 (2000)
  24. Hanahan D, "Hallmarks of Cancer : the Next Generation", Cell, 144(5), pp.646~674 (2011)
  25. Greten FR, "Inflammation and Cancer : Triggers, Mechanisms, and Consequences", Immunity, 51(1), pp.27~41 (2019)
  26. Kapuscinski J, "DAPI : a DNA-Specific Fluorescent Probe", Biotech Histochem, 70(5), pp.220~233 (1995)
  27. Doonan F, "Morphological assessment of apoptosis", Methods, 44(3), pp.200~204 (2008)
  28. Bruno Perillo, "ROS in cancer therapy: the bright side of the moon", Experimental and Molecular Medicine, 52, pp.1~12 (2020), 생화학분자생물학회[DOI]
  29. Loboda A, "Role of Nrf2", HO-1system in development, oxidative stress response and diseases : an evolutionarily conserved mechanism, 2016, pp.73(17), 3221~3247
  30. Wong PK, "Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2", Carcinogenesis, 29(6), pp.1235~1243 (2008)
  31. Hassan M, "Apoptosis and molecular targeting therapy in cancer", Biomed Res Int, 2014, pp.1~23 (2014)
  32. Budd RC, "Death receptors couple to both cell proliferation and apoptosis", J Clin Invest, 109(4), pp.437~478 (2002)
  33. Renault TT, "A brewing understanding of the regulation of Bax function by Bcl-xL and Bcl-2", Mech Ageing Dev, 161, pp.201~210 (2017)
  34. Zimmermann KC, "The machinery of programmed cell death", Pharmacol Ther, 92(1), pp.57~70 (2001)
  35. Boulares AH, "Role of Poly(ADP-ribose)Polymerase(PARP)Cleavage in Apoptosis", J Biol Chem, 274(33), pp.22932~22940 (1999)
  36. MulthoffG, "Chronic inflammation in cancer development", Front Immunol, 2, pp.1~17 (2011)
  37. Wiseman H, "Damage to DNA by Reactive Oxygen and Nitrogen Species: Role in Inflammatory Disease and Progression to Cancer", Biochem. J, 313, pp.17~29 (1996)
  38. Shrihari TG, "Inflammation Related Cancer-Highlights", J Carcinog Mutagen, 7(3), pp.2157~2158 (2016)
  39. Chiarugi V, "Cox-2, iNOS and p53 as play-makers of tumor angiogenesis", Int J Mol Med, 2(6), pp.715~724 (1998)
  40. Sethi G, "TNF : a master switch for inflammation to cancer", Front Biosci, 13(13), pp.5094~5201 (2008)
  41. Guo YQ, "Interleukin-6 signaling pathway in targeted therapy for cancer", Cancer Treat Rev, 38(7), pp.904~910 (2012)
  42. Laird BJ, "The Emerging Role of Interleukin 1β(IL-1β)in Cancer Cachexia", Inflammation, 44(4), pp.1223~1228 (2021)
  43. Vaux DL, "Apoptosis in the development and treatment of cancer", Carcinogenesis, 26(2), pp.263~333 (2005)

이 간행물의 다른 논문 (8건)

추출조건에 따른 陳橘 및 升麻 추출물의 미백 활성효과이영미, 송현우, 이보리, 나혜림, 송봉준, 이윤정pp. 24-36산후 요실금에 대한 침의 효과 : 체계적 문헌고찰 및 메타분석이수형, 김송백pp. 37-55갱년기 증후군으로 인한 불면의 침 치료 무작위 대조군 최신 연구의 체계적 문헌 고찰과 메타 분석윤영진, 박장경, 나지영pp. 56-73비정상 자궁 출혈의 한의학적 치료에 대한 국내 연구 동향 분석이지원, 김동철pp. 74-87부인과 수술 후 한방 조기 회복 치료를 받은 입원 환자에 대한 호전도 및 만족도 조사김혜원, 이지연, 유정은, 윤희재pp. 88-104
원문 보기